Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

NCT: NCT07240649 · NOT_YET_RECRUITING

NCT IDNCT07240649
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2035-12

Brief Summary

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Frequently Asked Questions

What is Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications?

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications is a clinical trial registered under NCT07240649. Current status: NOT_YET_RECRUITING.

What is the status of NCT07240649?

The current status of NCT07240649 (Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications) is: NOT_YET_RECRUITING.

When did Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications start?

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.